MedPath

Effectiveness of Mindfulness-based Cognitive Therapy Undergoing Post Stroke Rehabilitation

Not Applicable
Completed
Conditions
Rehabilitation
Mindfulness
Stroke
Interventions
Behavioral: Mindfulness-based intervention therapy
Other: usual care
Registration Number
NCT05844722
Lead Sponsor
National Institute for Medical Rehabilitation, Hungary
Brief Summary

The goal of this clinical trial is to investigate the efficacy of mindfulness-based cognitive therapy compared to usual care for stroke survivors undergoing inpatient rehabilitation.

Detailed Description

It was hypothesized that group-based MBCT would lead to improving mood, mindfulness, social support, physical, and neurocognitive function; and that these improvements would be maintained over the 3-month follow-up period. Participants in the control group received only usual care, the intervention group were involved in MBCT intervention in addition to usual care. MBCT intervention was designed to consist of eight 1.5-hour group sessions over 6 consecutive weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
93
Inclusion Criteria
  • stroke patients with functional impairments
  • confirmation of stroke by CT or MRI scan
  • age between 18-90 years
  • had adequate communication skills, cognitive and physical capacity to participate in study activities
  • competence to provide informed consent
Exclusion Criteria
  • severe cognitive impairment according to the Word List Learning Instrument (total score <7)
  • severe depression according to the Beck Depression Inventory (BDI) (total score>25)
  • history of severe mental illness (psychotic disorder, schizophrenia, severe depression, bipolar disorder, PTSD, suicidal tendencies)
  • the current change in the antidepressant therapy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MBCT groupMindfulness-based intervention therapyThe intervention group were involved in MBCT intervention in addition to usual care. MBCT intervention was designed to consist of eight 1.5-hour group sessions over 6 consecutive weeks.
Control groupusual careReceived usual care (standard multidisciplinary stroke care) over 6 weeks.
Primary Outcome Measures
NameTimeMethod
Change from 6 weeks on Beck Depression Inventory (BDI) at 3 months6 weeks and 3 months

Beck Depression Inventory (BDI) was used to assess severity of the depression with 21 items scored from 0 to 3 (hiv, Beck, 1961). Scores range from 0 to 63 with 0-9 representing normal value, 10-18 mild, 19-25 moderate, and ≥ 26 severe depression.

Change from baseline on Beck Depression Inventory (BDI) at 6 weeksBaseline and 6 weeks

Beck Depression Inventory (BDI) was used to assess severity of the depression with 21 items scored from 0 to 3 (hiv, Beck, 1961). Scores range from 0 to 63 with 0-9 representing normal value, 10-18 mild, 19-25 moderate, and ≥ 26 severe depression.

Change from baseline on The Spielberger State-Trait Anxiety Inventory (STAI-X) at 6 weeksBaseline and 6 weeks

The Spielberger State-Trait Anxiety Inventory (STAI-X) was used to assess anxiety both as a state and trait. State anxiety was measured by STAI form X-1, requiring participants to answer questions about how they feel right now. Trait anxiety was measured by the STAI form X-2, requiring participants to answer questions about how they feel generally. Both scales (X-1, X-2) consist of 20 items scored from 1 to 4. Scores range from 20 to 80 with higher scores representing higher state or trait anxiety.

Change from 6 weeks on The Spielberger State-Trait Anxiety Inventory (STAI-X) at 3 months6 weeks and 3 months

The Spielberger State-Trait Anxiety Inventory (STAI-X) was used to assess anxiety both as a state and trait. State anxiety was measured by STAI form X-1, requiring participants to answer questions about how they feel right now. Trait anxiety was measured by the STAI form X-2, requiring participants to answer questions about how they feel generally. Both scales (X-1, X-2) consist of 20 items scored from 1 to 4. Scores range from 20 to 80 with higher scores representing higher state or trait anxiety.

Secondary Outcome Measures
NameTimeMethod
Change from baseline on The Five Facet Mindfulness Questionnaire (FFMQ) at 6 weeksBaseline and 6 weeks

Five Facet Mindfulness Questionnaire (FFMQ) was used to assess mindfulness with 39 items scored from 1 to 5 with five subscales, including observing (8 items), describing (8), acting with awareness (8), nonjudging of inner experience (8), and nonreactivity to inner experience (7). Total scores range from 39 to 195 with higher scores representing higher mindfulness.

Change from 6 weeks on The Five Facet Mindfulness Questionnaire (FFMQ) at 3 months6 weeks and 3 months

Five Facet Mindfulness Questionnaire (FFMQ) was used to assess mindfulness with 39 items scored from 1 to 5 with five subscales, including observing (8 items), describing (8), acting with awareness (8), nonjudging of inner experience (8), and nonreactivity to inner experience (7). Total scores range from 39 to 195 with higher scores representing higher mindfulness.

Change from baseline on The Multidimensional Scale of Perceived Social Support Scale(MSPSS) at 6 weeksBaseline and 6 weeks

Multidimensional Scale of Perceived Social Support (MSPSS) was used to assess perceived social support receives from 3 different sources: family, friends, and significant other. The original version of the MSPSS is a 12-item scale scored from 0 to 6. The validated Hungarian version consists of 10 items scored from 1 to 5. Scores range from 10 to 50 with higher scores representing higher perceived social support.

Change from 6 weeks on The Multidimensional Scale of Perceived Social Support Scale (MSPSS) at 3 months6 weeks and 3 months

Multidimensional Scale of Perceived Social Support (MSPSS) was used to assess perceived social support receives from 3 different sources: family, friends, and significant other. The original version of the MSPSS is a 12-item scale scored from 0 to 6. The validated Hungarian version consists of 10 items scored from 1 to 5. Scores range from 10 to 50 with higher scores representing higher perceived social support.

Change from baseline on Touluose-Piéron test(TP) at 6 weeksBaseline and 6 weeks

Touluose-Piéron (TP) was used to assess sustained attention. This paper-pencil test consists of small boxes that have lines oriented in different directions, distributed in columns and rows. The task of the test is to examine the boxes and to mark those matching 4 model boxes, as quickly as possible within a limited time. Noted scores: the number of correct answers (CA), errored boxes (E), and omitted boxes (O). The Global Index of Attention and Perception (GIAP) is calculated by: CA- (E + O). Higher scores represent higher sustained attention.

Change from 6 weeks on Touluose-Piéron test(TP) at 3 months6 weeks and 3 months

Touluose-Piéron (TP) was used to assess sustained attention. This paper-pencil test consists of small boxes that have lines oriented in different directions, distributed in columns and rows. The task of the test is to examine the boxes and to mark those matching 4 model boxes, as quickly as possible within a limited time. Noted scores: the number of correct answers (CA), errored boxes (E), and omitted boxes (O). The Global Index of Attention and Perception (GIAP) is calculated by: CA- (E + O). Higher scores represent higher sustained attention.

Change from 6 weeks on Fugl-Meyer Assessment (FMA) at 3 months6 weeks and 3 months

Fugl-Meyer Assessment (FMA) is a clinician-measured instrument used to assess sensorimotor impairment in patients with post-stroke. It assess motor functioning, sensation, balance, joint range of motion and joint pain. The current study applied only the domain of the motor function (in the upper and lower extremities), and balance. The 57 items scored on a 3-point ordinal scale from 0 to 2, with a higher score representing less impairment. The motor score (M) ranges from 0 to 100; upper extremity (UE) 33 items with scores ranging from 0 to 66, lower extremity (LE) 17 items with scores ranging from 0 to 34. Balance 7 items scores from 0 to 14.

Change from 6 weeks on Functional Independence Measure (FIM) at 3 months6 weeks and 3 months

Functional Independence Measure (FIM) was used to assess the level of independence in basic activities of daily living. FIM is a clinician-measured instrument consisting of 13 motor and 5 cognitive items scored from 1 to 7. The higher the score, the more independent the patient. Scores from 1 to 5 indicate a need for assistance. The total score ranges from 18 and 126; the motor subscale score ranges from 13 to 91, and the cognitive subscale score ranges from 5 to 35.

Change from baseline on Fugl-Meyer Assessment (FMA) at 6 weeksBaseline and 6 weeks

Fugl-Meyer Assessment (FMA) is a clinician-measured instrument used to assess sensorimotor impairment in patients with post-stroke. It assess motor functioning, sensation, balance, joint range of motion and joint pain. The current study applied only the domain of the motor function (in the upper and lower extremities), and balance. The 57 items scored on a 3-point ordinal scale from 0 to 2, with a higher score representing less impairment. The motor score (M) ranges from 0 to 100; upper extremity (UE) 33 items with scores ranging from 0 to 66, lower extremity (LE) 17 items with scores ranging from 0 to 34. Balance 7 items scores from 0 to 14.

Change from baseline on Functional Independence Measure (FIM) at 6 weeksBaseline and 6 weeks

Functional Independence Measure (FIM) was used to assess the level of independence in basic activities of daily living. FIM is a clinician-measured instrument consisting of 13 motor and 5 cognitive items scored from 1 to 7. The higher the score, the more independent the patient. Scores from 1 to 5 indicate a need for assistance. The total score ranges from 18 and 126; the motor subscale score ranges from 13 to 91, and the cognitive subscale score ranges from 5 to 35.

Trial Locations

Locations (1)

National Institute for Medical Rehabilitation

🇭🇺

Budapest, Hungary

© Copyright 2025. All Rights Reserved by MedPath